OGT 2115
OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM) . OGT 2115 also inhibits heparan sulfate degradation activity[1][2].
Product Specifications
CAS Number
853929-59-6
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ogt-2115.html
Purity
99.62
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C(O)CC1=CC=C(OC(C2=CC=C(NC(/C=C/C3=CC=C(Br)C=C3)=O)C(F)=C2)=N4)C4=C1
Molecular Formula
C24H16BrFN2O4
Molecular Weight
495.30
References & Citations
[1][1]Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15 (9) :2295-9.|[2]Li Y, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013 May;31 (5) :1234-42.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1278576-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
TSGA10 cDNA Clone
Sign In for Pricing
View Details MBS1278576-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
TSGA10 cDNA Clone
Sign In for Pricing
View Details